Comments: NJ S1053 | 2022-2023 | Regular Session

Bill Title: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-01-31 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1053 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey S1053 at this time.

Social Comments on NJ S1053

feedback